Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Piperidone | HCID 12665 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 3'-(4-chloromethyl-phenyl)-4-(1,5-dimethyl-1H-pyrazol-4-ylmethyl)-3,4,5,6-tetrahydro-2H-[1,2']bipyrazinyl dihydrochloride | HCID 68594160 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 59321943 | HCID 59321943 | 73% |
Reaction Steps
Add sodium hydride (0.175 g of 60% weight suspension in mineral oil; 2.62 mmol) to a solution of piperidin-2-one (0.270 g; 2.73 mmol) in DMF (5 mL). Cool the mixture to 5° C., stir for 30 min., remove the cooling bath, warm to room temperature and stir for 30 min. Add 3′-(4-chloromethyl-phenyl)-4-(1,5-dimethyl-1H-pyrazol-4-ylmethyl)-3,4,5,6-tetrahydro-2H-[1,2′]bipyrazinyl dihydrochloride (0.253 g; 0.540 mmol) in 6 mL of DMF and stir for 20 hr. at room temperature. Quench with a solution of 10% aq. acetic acid (9 mL), add methanol (minimal volume to achieve a homogeneous solution) and add to a 5 gm SCX column (Varian; pre-rinsed with MeOH). Elute the crude product with 2 M ammonia in methanol (18 mL) and concentrate. Purify via chromatography on silica gel eluting 0-10% methanol/DCM to give 1-{4-[4-(1,5-dimethyl-1H-pyrazol-4-ylmethyl)-3,4,5,6-tetrahydro-2H-[1,2′]bipyrazinyl-3′-yl]-benzyl}-piperidin-2-one (0.180 g; 73%). MS (ES+) m/z: 460 (M+H)+. Purify by high pH reverse phase HPLC, and concentrate to give the free base. Dissolve the free base in acetonitrile and convert to the hydrochloride salt by adding 1 eq. 2 M aq. HCl solution. Add water and lyophilize to give the title compound as a brown powder (164 mg, 66%). MS (ES): m/z=460 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08202873B2 |
|---|
| Source dataset | uspto-grants-2012_06 |
|---|
| ORD ID | ord-43c545d0f637404a8d89c57e094cf652 |
|---|
| Source note | uspto-grants-2012_06 |
|---|